Vertex Pharmaceuticals Incorporated · NASDAQ:VRTX
Bunnage Mark E. sold 33 Vertex Pharmaceuticals Incorporated shares (Form 4)
Traded May 15, 2026 · Filed May 19, 2026
On May 15, 2026, Bunnage Mark E. (EVP, Chief Scientific Officer) sold 33 Vertex Pharmaceuticals Incorporated shares at US$453.45 for US$14,964 under a trading plan, leaving 7,284 shares. Filed May 19, 2026 (Form 4).
- Sold
- 33 shares
- Price
- US$453.45
- Value
- US$14,964
- Holding after
- 7,284 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | Sale | 33 | US$453.45 | 7,284 | Direct |